Mesothelioma research is extremely important to the eradication of Mesothelioma. Mesothelioma is a rare form of cancer that is cause by exposure to Asbestos. One of the most discouraging aspects of Mesothelioma is the fact that symptoms don't arise until 30-50 years after exposure to Asbestos. Even though Mesothelioma is a rare cancer, Mesothelioma research is required due to the fact that this cancer is hard to control. Mesothelioma research involves clinical trials and studies.
Today, legal cases abound regarding the claims of Mesothelioma and pointing the finger at various companies who unknowingly used Asbestos in their products. However, the focus needs to be set on Mesothelioma research and advancing the treatments available for those who suffer from this unfortunate cancer. It is also very hard to diagnose Mesothelioma because its symptoms are very similar to other conditions. This also lends to the importance of Mesothelioma research and testing.
One of the most important factors of Mesothelioma research is centered upon Asbestos, and its effect upon human cells. As Mesothelioma research continues to study the effects of Asbestos on healthy human cells, the possibility arises in finding ways to prevent damage as well as treat cells once they have been damaged due to Mesothelioma.
Currently, Mesothelioma research deals with Clinical trials. Clinical trials are not guaranteed to treat or cure Mesothelioma; they are part of scientist's best work at Mesothelioma research. Today, there are several clinical trials being administered to Mesothelioma patients in hopes of one day finding a cure. There are three new forms of clinical trials they are Photodynamic Therapy, Immunotherapy, and Intensity Modulated Radiation Therapy.
Photodynamic Therapy uses light in combination with drugs to target and kill damaged cells. Immunotherapy involves developing the body's own defense system or immune system to fight off the diseased cells. Finally, Intensity Modulated Radiation Therapy involves using radiation to target the diseased cells while not affecting the healthy cells.